Commission Regulation (EU) No. 500/2013 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, Adoxophyes orana granulovirus strain BV-0001, azoxystrobin, clothianidin, fenpyrazamine, heptamaloxyloglucan, metrafenone, Paecilomyces lilacinus strain 251, propiconazole, quizalofop-P, spiromesifen,
Country
Type of law
Legislation
Abstract
Annexes II, III and IV to Regulation (EC) No. 396/2005 are amended by these provisions as regards maximum residue levels for acetamiprid, Adoxophyes orana granulovirus strain BV-0001, azoxystrobin, clothianidin, fenpyrazamine, heptamaloxyloglucan, metrafenone, Paecilomyces lilacinus strain 251, propiconazole, quizalofop-P, spiromesifen, tebuconazole, thiamethoxam and zucchini yellow mosaik virus - weak strain in or on certain products.
Attached files
Web site
Date of text
Repealed
No
Serial Imprint
Official Journal of the European Union L 151, 4 June 2013, pp. 1-32.
Source language
English
Legislation status
in force
Legislation Amendment
No